Summary
The quinolones exhibit a selective suppressive effect on the intestinal microflora. The aerobic Gram-negative bacteria are strongly suppressed, while the aerobic Gram-positive bacteria are less affected, with ciprofloxacin and ofloxacin having the greatest effect. The anaerobic microflora is not affected by administration of norfloxacin, but is suppressed slightly by ciprofloxacin and ofloxacin, and moderately by sparfloxacin and temafloxacin. Very high concentrations of the quinolones are obtained in faeces, far exceeding the minimum inhibitory concentration for most aerobic and anaerobic bacteria. The discrepancy between in vivo and in vitro outcome is explained by the binding of the quinolones to faeces, and by inoculum effects. These ecological properties of the quinolones on the intestinal microflora make them suitable for treatment of bacterial enteric infections, selective decontamination and prophylaxis against travellers’ diarrhoea.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brumfitt W, Franklin I, Grady D, et al. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother 1984; 26: 757–61
Rozenberg-Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis 1985; 152: 104–7
Enzenberger R, Shah PM, Knothe H. Impact of oral ciprofloxacin on the faecal flora of healthy volunteers. Infection 1985; 13: 273–5
Bergan T, Delin C, Johansen S, et al. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and faecal microflora. Antimicrob Agents Chemother 1986; 29: 298–302
Van Saene JJM, Van Saene HKF, Geitz JN, et al. Quinolones and colonization resistance in human volunteers. Pharm Weekbl Sci Ed 1986; 8: 67–71
Holt HA, Lewis DA, White LO, et al. Effect of oral ciprofloxacin on the faecal flora of healthy volunteers. Eur J Clin Microbiol 1986; 5: 201–5
Esposito S, Barba D, Galante D, et al. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systematic encephalopathy. Drugs Exp Clin Res 1987; 10: 641–6
Ljungberg B, Nilsson-Ehle I, Edlund C, et al. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption. Scand J Infect Dis 1990; 22: 205–8
Brismar B, Edlund C, Malmborg AS, et al. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990; 34: 481–3
Wistrom J, Gentry LO, Palmgren AC, et al. Ecological effects of short term ciprofloxacin treatment of travellers’ diarrhoea. J Antimicrob Chemother 1992; 30: 69–706
Meckenstock R, Haralambie E, Linzenmeier G, et al. Die Beeinflussung der Darmflora durch Norfloxacin bei gesunden Menschen. Zac Z Antimikobr Antineoplast Chemother 1985; 1: 27–34
De Vries-Hospers HG, Welling GW, van der Waaij D. Norfloxacin for selective decontamination. A study in human volunteers. Prog Clin Biol Res 1985; 181: 259–62
Leigh DA, Emmanuel FXS, Tighe C, et al. Pharmacokinetic studies of norfloxacin in healthy volunteers and effect on the faecal flora. In: Ishigami J, editor. Recent advances in chemotherapy. Proceedings of the 14th International Congress of Chemotherapy; 1985 June 25–30; Kyoto. Tokyo: University of Tokyo Press, 1985: 1835–6
Pecquet S, Andremont A, Tancrede C. Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with human faecal flora. Antimicrob Agents Chemother 1986; 29: 1047–52
Edlund C, Bergan T, Josefsson K, et al. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis 1987; 19: 113–21
Edlund C, Lidbeck A, Kager L, et al. Effect of enoxacin on colonic microflora of healthy volunteers. Eur J Clin Microbiol 1987; 6: 298–300
Pecquet S, Andremont A, Tancrede C. Effect of ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother 1987; 31: 124–5
Edlund C, Kager L, Malmborg AS, et al. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol Infect Dis 1988; 7: 135–43
Vollaard EJ, Clasener HAL, Janssen AJHM. Influence of pefloxacin on microbial colonization resistance in healthy volunteers. Eur J Clin Microbiol Infect Dis 1992; 11: 257–60
Edlund C, Brismar B, Nord CE. Effect of lomefloxacin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 1990; 9: 35–9
Ritz M, Lode H, Fassbender M, et al. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother 1994; 38: 455–9
Brismar B, Edlund C, Nord CE. Effect of temafloxacin on the normal intestinal microflora. Clin Pharm Res. In press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nord, C.E. Effect of Quinolones on the Human Intestinal Microflora. Drugs 49 (Suppl 2), 81–85 (1995). https://doi.org/10.2165/00003495-199500492-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199500492-00013